Chr. Hansen Holding A/S
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CRTSF research report →
Companywww.chr-hansen.com
Chr. Hansen Holding A/S, a bioscience company, develops natural ingredient solutions for the food, nutritional, pharmaceutical, and agricultural industries in Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific. The company operates through Food Cultures & Enzymes, and Health & Nutrition segments.
- CEO
- Mauricio Graber
- IPO
- 2012
- Employees
- 3,834
- HQ
- Horsholm, DK
Price Chart
Valuation
- Market Cap
- $10.44B
- P/E
- 42.76
- P/S
- 7.25
- P/B
- 5.11
- EV/EBITDA
- 20.36
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 54.20%
- Op Margin
- 26.89%
- Net Margin
- 17.01%
- ROE
- 21.82%
- ROIC
- 9.20%
Growth & Income
- Revenue
- $1.33B · 9.56%
- Net Income
- $227.00M · 0.84%
- EPS
- $1.72 · 0.58%
- Op Income
- $358.80M
- FCF YoY
- 20.04%
Performance & Tape
- 52W High
- $79.54
- 52W Low
- $61.43
- 50D MA
- $67.10
- 200D MA
- $71.64
- Beta
- 0.33
- Avg Volume
- 76
Get TickerSpark's AI analysis on CRTSF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CRTSF Coverage
We haven't published any research on CRTSF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CRTSF Report →